Antifungal susceptibility testing of fluconazole by flow cytometry correlates with clinical outcome

被引:25
作者
Wenisch, C
Moore, CB
Krause, R
Presterl, E
Pichna, P
Denning, DW
机构
[1] Graz Univ, Dept Med, Div Infect Dis, A-8036 Graz, Austria
[2] Univ Hosp Vienna, Dept Med, Div Infect Dis, Vienna, Austria
[3] Hope Hosp, Dept Microbiol, Manchester, Lancs, England
关键词
D O I
10.1128/JCM.39.7.2458-2462.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Susceptibility testing of fungi by flow cytometry (also called fluorescence-activated cell sorting [FACS]) using vital staining with FUN-1 showed a good correlation with the standard M27-A procedure for assessing MICs. In this study we determined MICs for blood culture isolates from patients with candidemia by NCCLS M27-A and FAGS methods and correlated the clinical outcome of these patients with in vitro antifungal resistance test results, A total of 24 patients with candidemia for whom one or more blood cultures were positive for a Candida sp. were included. Susceptibility testing was performed by NCCLS M27-A and FACS methods. The correlation of MICs (NCCLS M27-A and FAGS) and clinical outcome was calculated. In 83% of the cases, the MICs of fluconazole determined by FAGS were within 1 dilution of the MICs determined bg the NCCLS M27-A method. For proposed susceptibility breakpoints, there was 100% agreement between the M27-A and FAGS methods. In the FAGS assay, a fluconazole MIC of <1 mug/ml was associated with cure (P < 0.001) whereas an MIC of greater than or equal to1 mug/ml was associated with death (P < 0.001), The M27-A-derived fluconazole MICs did not correlate with outcome (P = 1 and P = 0.133).
引用
收藏
页码:2458 / 2462
页数:5
相关论文
共 28 条
[1]   CORRELATION BETWEEN IN-VITRO AND IN-VIVO ACTIVITY OF ANTIFUNGAL AGENTS AGAINST CANDIDA SPECIES [J].
ANAISSIE, EJ ;
KARYOTAKIS, NC ;
HACHEM, R ;
DIGNANI, MC ;
REX, JH ;
PAETZNICK, V .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (02) :384-389
[2]   Characterization and quantitation of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model [J].
Andes, D ;
van Ogtrop, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) :2116-2120
[3]  
Bodey G. P, 1993, CANDIDIASIS PATHOGEN
[4]   THE EMERGENCE OF FUNGI AS MAJOR HOSPITAL PATHOGENS [J].
BODEY, GP .
JOURNAL OF HOSPITAL INFECTION, 1988, 11 :411-426
[5]   RESULTS OF A SURVEY OF ANTIFUNGAL SUSCEPTIBILITY TESTS IN THE UNITED-STATES AND INTERLABORATORY COMPARISON OF BROTH DILUTION TESTING OF FLUCYTOSINE AND AMPHOTERICIN-B [J].
CALHOUN, DL ;
ROBERTS, GD ;
GALGIANI, JN ;
BENNETT, JE ;
FEINGOLD, DS ;
JORGENSEN, J ;
KOBAYASHI, GS ;
SHADOMY, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 23 (02) :298-301
[6]   COMPARISON OF RELATIVE SUSCEPTIBILITIES OF CANDIDA SPECIES TO 3 ANTIFUNGAL AGENTS AS DETERMINED BY UNSTANDARDIZED METHODS [J].
GALGIANI, JN ;
REISER, J ;
BRASS, C ;
ESPINELINGROFF, A ;
GORDON, MA ;
KERKERING, TM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (09) :1343-1347
[7]   Susceptibility testing of fungi: Current status of correlation of in vitro data with clinical outcome [J].
Ghannoum, MA ;
Rex, JH ;
Galgiani, JN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (03) :489-495
[8]   TREATMENT OF CANDIDA-ALBICANS FUNGEMIA WITH FLUCONAZOLE [J].
GRANINGER, W ;
PRESTERIL, E ;
SCHNEEWEISS, B ;
TELEKY, B ;
GEORGOPOULOS, A .
JOURNAL OF INFECTION, 1993, 26 (02) :133-146
[9]   RAPID-DETERMINATION OF ANTIFUNGAL ACTIVITY BY FLOW-CYTOMETRY [J].
GREEN, L ;
PETERSEN, B ;
STEIMEL, L ;
HAEBER, P ;
CURRENT, W .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (04) :1088-1091
[10]   Rapid susceptibility testing of Candida albicans by flow cytometry [J].
Kirk, SM ;
Callister, SM ;
Lim, LCL ;
Schell, RF .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (02) :358-363